RXI PHARMACEUTICALS CORP NEW's ticker is RXIIXXXX and the CUSIP is 74979C501. A total of 20 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $12,000 | -20.0% | 26,638 | 0.0% | 0.00% | – |
| Q2 2017 | $15,000 | -28.6% | 26,638 | 0.0% | 0.00% | – |
| Q1 2017 | $21,000 | +10.5% | 26,638 | 0.0% | 0.00% | – |
| Q4 2016 | $19,000 | -60.4% | 26,638 | 0.0% | 0.00% | – |
| Q3 2016 | $48,000 | -23.8% | 26,638 | 0.0% | 0.00% | – |
| Q2 2016 | $63,000 | – | 26,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 316,010 | $585,000 | 0.05% |
| Renaissance Technologies | 181,780 | $336,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 38 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 684 | $1,000 | 0.00% |
| UBS Group AG | 8,868 | $16,000 | 0.00% |
| NEXT Financial Group, Inc | 6 | $0 | 0.00% |
| WealthPLAN Partners, LLC | 1 | $2,000 | 0.00% |
| IFP Advisors, Inc | 101 | $0 | 0.00% |
| Advisor Group, Inc. | 163 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 26,638 | $48,000 | 0.00% |